179 related articles for article (PubMed ID: 38149798)
1. Severity of coronary artery disease is associated with diminished circANRIL expression: A possible blood based transcriptional biomarker in East Africa.
Akan G; Nyawawa E; Nyangasa B; Turkcan MK; Mbugi E; Janabi M; Atalar F
J Cell Mol Med; 2024 Feb; 28(3):e18093. PubMed ID: 38149798
[TBL] [Abstract][Full Text] [Related]
2. Multiple Non-coding ANRIL Transcripts Are Associated with Risk of Coronary Artery Disease: a Promising Circulating Biomarker.
Fang J; Pan Z; Wang D; Lv J; Dong Y; Xu R; Jin Y; Sheng J; Yin X; Xie X; Wang X; Guo X
J Cardiovasc Transl Res; 2021 Apr; 14(2):229-237. PubMed ID: 32572690
[TBL] [Abstract][Full Text] [Related]
3. Association between Long Noncoding RNA ANRIL Expression Variants and Susceptibility to Coronary Artery Disease.
Yari M; Bitarafan S; Broumand MA; Fazeli Z; Rahimi M; Ghaderian SMH; Mirfakhraie R; Omrani MD
Int J Mol Cell Med; 2018; 7(1):1-7. PubMed ID: 30234067
[TBL] [Abstract][Full Text] [Related]
4. Splice variants of lncRNA RNA ANRIL exert opposing effects on endothelial cell activities associated with coronary artery disease.
Cho H; Li Y; Archacki S; Wang F; Yu G; Chakrabarti S; Guo Y; Chen Q; Wang QK
RNA Biol; 2020 Oct; 17(10):1391-1401. PubMed ID: 32602777
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of the 9p21.3 CAD risk locus in Asian Indians.
Shanker J; Arvind P; Jambunathan S; Nair J; Kakkar V
Thromb Haemost; 2014 May; 111(5):960-9. PubMed ID: 24452806
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA
Cho H; Shen GQ; Wang X; Wang F; Archacki S; Li Y; Yu G; Chakrabarti S; Chen Q; Wang QK
J Biol Chem; 2019 Mar; 294(11):3881-3898. PubMed ID: 30655286
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of circulating lncRNA ANRIL and its correlation with coronary artery disease parameters.
Hu Y; Hu J
Braz J Med Biol Res; 2019; 52(8):e8309. PubMed ID: 31411246
[TBL] [Abstract][Full Text] [Related]
8. Associations between low serum levels of ANRIL and some common gene SNPs in Iranian patients with premature coronary artery disease.
Taheri Bajgan E; Zahedmehr A; Shakerian F; Maleki M; Bakhshandeh H; Mowla SJ; Malakootian M
Sci Rep; 2024 Jan; 14(1):1244. PubMed ID: 38218954
[TBL] [Abstract][Full Text] [Related]
9. Association of ANRIL Expression with Coronary Artery Disease in Type 2 Diabetic Patients.
Rahimi E; Ahmadi A; Boroumand MA; Mohammad Soltani B; Behmanesh M
Cell J; 2018 Apr; 20(1):41-45. PubMed ID: 29308617
[TBL] [Abstract][Full Text] [Related]
10. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.
Holdt LM; Beutner F; Scholz M; Gielen S; Gäbel G; Bergert H; Schuler G; Thiery J; Teupser D
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):620-7. PubMed ID: 20056914
[TBL] [Abstract][Full Text] [Related]
11. Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease.
Zhuang J; Peng W; Li H; Wang W; Wei Y; Li W; Xu Y
PLoS One; 2012; 7(10):e47193. PubMed ID: 23091611
[TBL] [Abstract][Full Text] [Related]
12. Effects of ANRIL polymorphisms on the likelihood of coronary artery disease: A meta-analysis.
Xie Y; Zhao D; Dong P; Wang H; Li D; Lai L
J Cell Biochem; 2019 Apr; 120(4):6113-6119. PubMed ID: 30387168
[TBL] [Abstract][Full Text] [Related]
13. The roles of ANRIL polymorphisms in coronary artery disease: a meta-analysis.
Hu L; Su G; Wang X
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 30814313
[TBL] [Abstract][Full Text] [Related]
14. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks.
Holdt LM; Hoffmann S; Sass K; Langenberger D; Scholz M; Krohn K; Finstermeier K; Stahringer A; Wilfert W; Beutner F; Gielen S; Schuler G; Gäbel G; Bergert H; Bechmann I; Stadler PF; Thiery J; Teupser D
PLoS Genet; 2013; 9(7):e1003588. PubMed ID: 23861667
[TBL] [Abstract][Full Text] [Related]
15. Variants in ANRIL gene correlated with its expression contribute to myocardial infarction risk.
Cheng J; Cai MY; Chen YN; Li ZC; Tang SS; Yang XL; Chen C; Liu X; Xiong XD
Oncotarget; 2017 Feb; 8(8):12607-12619. PubMed ID: 28107200
[TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis for the identification of hub genes and signaling pathways related to circANRIL.
Qin Q; Zheng P; Tu R; Huang J; Cao X
PeerJ; 2022; 10():e13135. PubMed ID: 35497183
[TBL] [Abstract][Full Text] [Related]
17. ANRIL rs2383207 polymorphism and coronary artery disease (CAD) risk: a meta-analysis with observational studies.
Wang P; Dong P; Yang X
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):6-10. PubMed ID: 27894414
[TBL] [Abstract][Full Text] [Related]
18. Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.
Gormez S; Erdim R; Akan G; Caynak B; Duran C; Gunay D; Sozer V; Atalar F
Cardiovasc Pathol; 2020; 46():107192. PubMed ID: 31927390
[TBL] [Abstract][Full Text] [Related]
19. Analysis of ANRIL Isoforms and Key Genes in Patients with Severe Coronary Artery Disease.
Rodríguez-Esparragón F; Torres-Mata LB; Cazorla-Rivero SE; Serna Gómez JA; González Martín JM; Cánovas-Molina Á; Medina-Suárez JA; González-Hernández AN; Estupiñán-Quintana L; Bartolomé-Durán MC; Rodríguez-Pérez JC; Varas BC
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003316
[TBL] [Abstract][Full Text] [Related]
20. The Association of ANRIL With Coronary Artery Disease And Aortic Aneurysms, How Far Does The Gene Desert Go?
Ng WC; Chan J; Tarkas TN; Meharban N; Munir W; Bashir M
Ann Vasc Surg; 2022 Mar; 80():345-357. PubMed ID: 34780941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
